Technical analysis of GeoVax Labs, Inc. (GOVX): price and volume charts, candlestick patterns, moving averages (SMA, EMA), RSI, MACD, ADX and Bollinger Bands. Identify momentum, trend direction and potential entry/exit zones.
GeoVax Labs, Inc. is a biotechnology company in the clinical development phase, focused on creating innovative human vaccines and immunotherapies. The firm targets both infectious diseases and various cancer types, utilizing its proprietary modified vaccinia ankara (MVA) virus-like particle (VLP) vaccine platform.
Price Performance
| 1 month | -37.71% |
| 3 months | -69.76% |
| Year-to-date | -90.53% |
| 1 year | -97.62% |
| 3 years | -99.80% |
| 5 years | -99.98% |
52-Week Range
| 52-week High | $17.74 |
| 52-week Low | $0.40 |
| Avg Volume (90d) | 3.8M |
Technical Indicators
| SMA 50 | $0.73 |
| SMA 200 | $2.26 |
| 30-day Volatility (annualised) | 86.6% |
| Price vs SMA 50 | -44.4% |
| Price vs SMA 200 | -82.1% |
Monthly Close (12 months)
| Month | Close | Change |
|---|
| 2025-10 | $14.14 | |
| 2025-11 | $10.28 | -27.3% |
| 2025-12 | $4.28 | -58.4% |
| 2026-01 | $2.80 | -34.6% |
| 2026-02 | $1.60 | -42.9% |
| 2026-03 | $1.38 | -13.8% |
| 2026-04 | $1.09 | -21.0% |
| 2026-05 | $2.06 | +89.0% |
| 2026-06 | $1.27 | -38.3% |
| 2026-07 | $0.68 | -46.4% |
| 2026-08 | $0.63 | -7.2% |
| 2026-09 | $0.41 | -35.9% |
Upcoming Earnings
| Date | EPS Est. | Revenue Est. |
|---|
| 2026-09-14 | | |
| 2026-09-14 | | |
| 2026-09-14 | | |
| 2026-09-14 | | |
| 2026-09-14 | | $144M |
| 2026-09-14 | | $898M |
Price
| Price | $0.41 |
| Market Cap | $3M |
| Exchange | NASDAQ |
| Country | US |
Valuation Ratios
| Price / Book | 1.05 |
| EV / EBITDA | -0.09 |
| Dividend Yield | 0.00% |
Financial Health
| Debt / Equity | 0.18 |
| Current Ratio | 1.54 |
| Piotroski F-Score | 2 |
| Altman Z-Score | -42.54 |